PD-0332991
A5481008
Phase 3 small_molecule completed
Quick answer
PD-0332991 for Breast Neoplasms is a Phase 3 program (small_molecule) at Pfizer with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer
- Indication
- Breast Neoplasms
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed